A drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and…

Trigemina, a company focused on creating non-narcotic pain relief drugs, is enrolling patients in a Phase II clinical trial of inhaled oxytocin to treat chronic migraine. Trigemina's oxytocin product…

Discovery of a new protein that controls the presence of the Vel blood group antigen on our red blood cells will make it possible to use simple DNA testing to find blood donors for patients who lack…

In a two-year sub-study of the STAMPEDE (Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently) trial, researchers  evaluated the effects of bariatric surgery and intensive…

Every year in Germany, approximately 280,000 people suffer a myocardial infarction; more than 52,000 die as a result. Due to an occluded vessel, parts of the heart muscle no longer have sufficient…

Surgeon Paolo Macchiarini,  Professor of Regenerative Surgery at Karolinska Institutet, has become famous worldwide due to successfully transplanting bioengineered stem cell-based trachea,…

Researchers from the Universitat Autònoma de Barcelona report they can cure diabetes in large animals with a single session of gene therapy. Writing in Diabetes, they said the dogs recovered their…

The European Food Safety Authority (EFSA) has reviewed field performance data of the BOVIGAM(R)Interferon-gamma (IFN-gamma) test and recommended such tests for inclusion in the official list of stand…

By combining insulin and an inhibitor of the epidermal growth factor (EGF) betacellulin,  Cleveland Clinic researcher Bela Anand-Apte, MD, PhD was able to halt the progression of diabetic…

Scientists have discovered a new gene mechanism that appears to regulate triglyceride levels and may protect carriers of a gene variant against cardiovascular disease, especially among those with…